UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 11-K
(Mark One)
x ANNUAL REPORT PURSUANT TO SECTION 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the fiscal year ended December 31, 2009
OR
o TRANSITION REPORT PURSUANT TO SECTION 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the transition period from to
Commission file number: 0-21116
A. Full title of the plan and the address of the plan, if different from that of the issuer named below:
USANA Health Sciences 401(k) Plan
B. Name of issuer of the securities held pursuant to the plan and the address of its principal executive office.
USANA HEALTH SCIENCES, INC.
3838 West Parkway Blvd., Salt Lake City, Utah 84120
(Address of principal executive offices, Zip Code)
USANA HEALTH SCIENCES, INC.
FORM 11-K
For the Year Ended December 31, 2009
| Page |
|
|
3 | |
Financial Statements: |
|
4 | |
5 | |
6 - 10 | |
11 | |
12 | |
|
|
|
|
13 |
* Other supplementary schedules required by section 2520-103.10 of the Department of Labors Rules and Regulations for Reporting and Disclosure under the Employee Retirement Income Security Act of 1974 have been omitted because they are not applicable.
REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
The Administrators of the
USANA Health Sciences 401(k) Plan
We have audited the accompanying statements of assets available for benefits of the USANA Health Sciences 401(k) Plan (the Plan) as of December 31, 2009 and 2008, and the related statement of changes in assets available for benefits for the year ended December 31, 2009. These financial statements and the supplemental schedule are the responsibility of the Plans management. Our responsibility is to express an opinion on the financial statements based on our audits.
We conducted our audits in accordance with the standards of the Public Company Accounting Oversight Board (United States). Those standards require that we plan and perform the audits to obtain reasonable assurance about whether the financial statements are free of material misstatement. The Plan has determined it is not required to have, nor were we engaged to perform, an audit of its internal control over financial reporting. Our audits included consideration of internal control over financial reporting as a basis for designing audit procedures that are appropriate in the circumstances, but not for the purpose of expressing an opinion on the effectiveness of the Plans internal control over financial reporting. Accordingly, we express no such opinion. An audit includes examining, on a test basis, evidence supporting the amounts and disclosures in the financial statements. An audit also includes assessing the accounting principles used and significant estimates made by management, as well as evaluating the overall financial statement presentation. We believe that our audits provide a reasonable basis for our opinion.
In our opinion, the financial statements referred to above present fairly, in all material respects, the assets available for benefits of the USANA Health Sciences 401(k) Plan as of December 31, 2009 and 2008, and the changes in assets available for benefits for the year ended December 31, 2009 in conformity with U.S. generally accepted accounting principles.
Our audits were made for the purpose of forming an opinion on the basic financial statements taken as a whole. The supplemental Schedule of Assets (Held at End of Year) as of December 31, 2009 is presented for the purpose of additional analysis and is not a required part of the basic financial statements, but is supplementary information required by the United States Department of Labors Rules and Regulations for Reporting and Disclosure under the Employee Retirement Income Security Act of 1974. The supplemental schedule has been subjected to the auditing procedures applied in the audit of the basic financial statements and, in our opinion, is fairly stated in all material respects in relation to the basic financial statements taken as a whole.
/s/ Tanner LC
Salt Lake City, Utah
June 17, 2010
USANA Health Sciences 401(k) Plan
Statements of Assets Available for Benefits
|
| December 31, |
| ||||
|
| 2009 |
| 2008 |
| ||
|
|
|
|
|
| ||
Assets |
|
|
|
|
| ||
Investments, at fair value |
|
|
|
|
| ||
Mutual funds |
| $ | 17,132,355 |
| $ | 12,235,157 |
|
USANA Health Sciences, Inc. common stock |
| 2,210,424 |
| 2,412,761 |
| ||
Loans to participants |
| 794,563 |
| 633,556 |
| ||
|
|
|
|
|
| ||
Total investments |
| 20,137,342 |
| 15,281,474 |
| ||
|
|
|
|
|
| ||
Cash |
| 8,065 |
| 8,065 |
| ||
|
|
|
|
|
| ||
Employer contributions receivable |
| |
| 7,828 |
| ||
|
|
|
|
|
| ||
Assets available for benefits |
| $ | 20,145,407 |
| $ | 15,297,367 |
|
The accompanying notes are an integral part of these statements.
USANA Health Sciences 401(k) Plan
Statement of Changes in Assets Available for Benefits
Year Ended December 31, 2009
Additions to (deductions from) assets attributable to: |
|
|
| |
|
|
|
| |
Investment income: |
|
|
| |
Net appreciation in fair value of investments |
| $ | 3,447,113 |
|
Interest and dividends |
| 373,837 |
| |
|
|
|
| |
Total investment gain |
| 3,820,950 |
| |
|
|
|
| |
Contributions: |
|
|
| |
Employee |
| 1,901,871 |
| |
Employer |
| 897,839 |
| |
|
|
|
| |
Total contributions |
| 2,799,710 |
| |
|
|
|
| |
Benefits paid to participants |
| (1,772,620 | ) | |
|
|
|
| |
Net increase in assets available for benefits |
| 4,848,040 |
| |
|
|
|
| |
Assets available for benefits: |
|
|
| |
Beginning of year |
| 15,297,367 |
| |
|
|
|
| |
End of year |
| $ | 20,145,407 |
|
The accompanying notes are an integral part of this statement.
USANA Health Sciences 401(k) Plan
NOTE A DESCRIPTION OF THE PLAN
The following description of the USANA Health Sciences 401(k) Plan (the Plan) provides only general information. Participants and other financial statement users should refer to the Plan agreement for a more complete description of the Plans provisions.
1. General
The Plan is a defined contribution plan covering all United States employees of USANA Health Sciences, Inc. (the Company or the Employer) who have completed one month of service and are age 18 or older. The Plan is subject to the provisions of the Employee Retirement Income Security Act of 1974 (ERISA), as amended, and permits traditional 401(k) deferrals (pre-tax), as well as Roth 401(k) deferrals (after-tax).
2. Contributions
Each year participants may elect to contribute up to 75 percent of their annual compensation subject to certain limits as defined in the Plan. Contributions are limited by the Internal Revenue Code, which established a maximum contribution of $16,500 ($22,000 for participants over age 50) for the year ended December 31, 2009. Participants may elect to make pre-tax contributions and/or after-tax Roth elective contributions into their accounts. Participants may also contribute amounts representing distributions from certain other defined benefit or defined contribution plans. Under the Safe Harbor and certain other provisions of the Plan, eligible employees who have not made an affirmative election to defer or not defer will have elective deferrals withheld in the amount of six percent of their compensation, to be invested in the appropriate target date retirement fund. Participants may direct their investments into one or more of the investment options offered by the Plan, with no more than 25 percent of their investment allocations directed into shares of the Companys common stock.
The Company provides a matching contribution equal to 100 percent of the first one percent of a participants compensation that is contributed as an elective deferral by the participant, and 50 percent of that elective deferral between one and six percent of the participants compensation. The Companys board of directors may also authorize additional contributions to the Plan.
3. Participant accounts
Individual accounts are maintained for each Plan participant. Each participants account is adjusted for the participants contributions and allocations of (a) the Companys contributions and (b) investment gains or losses. The allocation of the Companys discretionary contributions and forfeitures is based on each participants contribution, as defined by the Plan. The allocation of investment gains or losses is based on a participants weighted-average account balance, as defined by the Plan.
4. Vesting
Participants are fully vested in their voluntary contributions, including any net investment gains on those contributions. The Companys matching and discretionary contributions fully vest at the end of two years of service.
5. Participant loans
A participant may borrow a minimum of $1,000 up to a maximum equal to the lesser of $50,000 or 50 percent of his or her vested account balance. Each participant loan is secured by the balance in the participants account and bears interest at rates ranging from 4.25 percent to 11.00 percent, which rates were commensurate with local prevailing rates at the time of loan origination. Principal and interest is paid ratably through payroll deductions. Loans are re-paid over five-year periods, unless the loan was used to purchase a principal residence, in which case the payback period may not exceed 30 years. As of December 31, 2009, the Plan had participant loans outstanding with maturities ranging from 2010 through 2019.
6. Benefits paid to participants
On termination of service due to death, permanent disability, or retirement, a participant or beneficiary may receive a lump-sum amount equal to the value of the participants vested interest in his or her account. For termination of service due to other reasons, the Plan may make a lump-sum distribution of the value of the participants vested interest in his or her account where the account balance is less than $5,000.
USANA Health Sciences 401(k) Plan
NOTES TO FINANCIAL STATEMENTS - CONTINUED
NOTE A DESCRIPTION OF THE PLAN CONTINUED
7. Forfeited accounts
Forfeited accounts related to the Companys matching contributions are used to reduce future matching contributions. As of December 31, 2009 and 2008, the balance of forfeited accounts totaled $52,900 and $8,431, respectively. During 2009, forfeitures totaled $60,838 and the Companys contributions were reduced by $14,866 from the application of forfeitures. Losses on forfeited balances were $1,503 during 2009.
8. Expenses
The Company, as the Plan sponsor, pays all administrative expenses of the Plan.
9. Plan amendments
During 2009, the Plan document was amended to (1) shorten the required service period for eligibility from three months to one month, (2) change the entry date into the Plan from the first day of each calendar quarter to as soon as eligibility requirements are met, and (3) allow participants to change their deferral contribution percentage each payroll period instead of on a quarterly basis.
NOTE B SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
1. Basis of accounting
The financial statements of the Plan are presented using the accrual method of accounting in accordance with accounting principles generally accepted in the United States of America (US GAAP).
2. Use of estimates
The preparation of the financial statements in conformity with US GAAP requires the Plan management to make estimates and assumptions that affect certain reported amounts of assets available for benefits at the date of the financial statements, the changes in assets available for benefits during the reporting period and, when applicable, the disclosure of contingent assets and liabilities at the date of the financial statements. Actual results may differ from those estimates.
3. Recent accounting pronouncements
In June 2009, the Financial Accounting Standards Board (FASB) issued Accounting Standards Codification (ASC) 105, Generally Accepted Accounting Principles, which establishes the FASB Accounting Standards Codification as the source of authoritative accounting principles recognized by the FASB to be applied by nongovernmental entities in the preparation of financial statements in conformity with US GAAP. Rules and interpretive releases of the Securities and Exchange Commission (SEC) are also sources of authoritative US GAAP for SEC registrants. ASC 105 is effective for annual financial periods ending after September 15, 2009. The Plan adopted ASC 105 during the year ended December 31, 2009. The adoption had no impact on the Plans financial statements.
In May 2009, the FASB issued ASC 855, Subsequent Events, which establishes general accounting standards and disclosure requirements for events that occur after the balance sheet date but before the financial statements are issued or are available to be issued. In February 2010, the FASB issued Accounting Standards Update (ASU) No. 2010-09, Subsequent Events (Topic 855): Amendments to Certain Recognition and Disclosure Requirements (ASU 2010-09). ASU 2010-09 amends Subtopic 855-10, Subsequent Events Overall to no longer require that SEC filers disclose the date for both issued and revised financial statements through which subsequent events were evaluated. The Plan adopted these standards upon issuance and the application had no impact on the Plans financial statements.
USANA Health Sciences 401(k) Plan
NOTES TO FINANCIAL STATEMENTS - CONTINUED
NOTE B SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES CONTINUED
In January 2010, the FASB issued ASU No. 2010-06, Fair Value Measurements and Disclosures (Topic 820): Improving Disclosures about Fair Value Measurements (ASU 2010-06). ASU 2010-06 amends Subtopic 820-10 to require disclosure of the transfers in and out of Levels 1 and 2. The update also requires additional information for Level 3 related to purchases, sales, issuances and settlements, and requires more detailed disclosure regarding valuation techniques and inputs. ASU 2010-06 as it relates to Levels 1 and 2 is effective for fiscal years and interim periods beginning after December 15, 2009. Requirements relating to Level 3 are effective for fiscal years and interim periods beginning after December 15, 2010. The Plan adopted the current effective provisions of ASU 2010-06 during January 2010, and its application is not expected to have a material impact on the Plans financial statements.
4. Investment valuation and income recognition
The Plans investments are stated at fair value. Quoted market prices are used to value investments in shares of USANA Health Sciences, Inc. common stock (which are held in a unitized stock fund) and in mutual funds. Shares of mutual funds are valued at the net asset value of shares held by the Plan at year-end. Participant loans are valued at their outstanding balances, which approximate fair value. Net appreciation (depreciation) caused by fluctuations in the value of investments is reflected in the Statement of Changes in Assets Available for Benefits. Amounts invested may earn interest and dividends, which in turn are reinvested.
Purchases and sales of securities are recorded on a trade-date basis. Income from interest is recorded on the accrual basis. Dividends are recorded on the ex-dividend date. Earnings and losses within each fund are allocated to participants based on their proportionate shares in the fund.
In general, the Plans securities are exposed to various risks, such as interest rate, credit, and overall market volatility. Due to the level of risk associated with certain investment securities, it is reasonably possible that changes in the values of investment securities will occur in the near term and that such changes could materially affect the amounts reported in the accompanying statements of assets available for benefits.
5. Benefits paid to participants
Benefits are recorded when paid. As of December 31, 2009, there were no distributions that had been requested but not paid.
NOTE C INVESTMENTS
All investment options are participant-directed. The following is a summary of the fair value of the Plans investments as of December 31, 2009 and 2008. Investments representing five percent or more of assets available for benefits at the end of each year are separately identified.
|
| 2009 |
| 2008 |
| ||
|
|
|
|
|
| ||
The Growth Fund of America |
| $ | 2,864,086 |
| $ | 2,029,643 |
|
EuroPacific Growth Fund |
| 2,486,288 |
| 1,559,864 |
| ||
USANA Health Sciences, Inc. common stock |
| 2,210,424 |
| 2,412,761 |
| ||
Washington Mutual Investors Fund |
| 2,182,328 |
| 1,825,722 |
| ||
SMALLCAP World Fund |
| 1,935,743 |
| 1,202,092 |
| ||
Money Market Fund |
| 1,435,047 |
| 1,314,336 |
| ||
Fundamental Investors |
| 1,287,068 |
| 856,657 |
| ||
The Income Fund of America |
| 1,286,710 |
| 1,136,086 |
| ||
Other |
| 4,449,648 |
| 2,944,313 |
| ||
|
|
|
|
|
| ||
Total Investments |
| $ | 20,137,342 |
| $ | 15,281,474 |
|
USANA Health Sciences 401(k) Plan
NOTES TO FINANCIAL STATEMENTS CONTINUED
NOTE C INVESTMENTS CONTINUED
Net appreciation (depreciation) in the value of investments includes all investments bought and sold during the year, as well as held at year-end. During the year ended December 31, 2009, the Plans investments appreciated (depreciated) in value as follows:
Mutual Funds |
| $ | 3,572,009 |
|
Common Stock |
| (124,896 | ) | |
|
|
|
| |
|
| $ | 3,447,113 |
|
NOTE D FAIR VALUE MEASUREMENTS
The Plan reports investments and participant loans in accordance with established authoritative guidance, which requires a three-level valuation hierarchy for disclosure of fair value measurements. The valuation hierarchy is based upon the transparency of inputs to the valuation of an asset or liability as of the measurement date.
The three levels are defined as follows:
· Level 1 inputs are quoted market prices in active markets for identical assets or liabilities that are accessible at the measurement date.
· Level 2 inputs are from other than quoted market prices included in Level 1 that are observable for the asset or liability, either directly or indirectly.
· Level 3 inputs are unobservable and are used to measure fair value in situations where there is little, if any, market activity for the asset or liability at the measurement date.
The following schedule sets forth by level within the valuation hierarchy a summary of the Plans investments and participant loans, measured at fair value as of the dates indicated:
|
| Level 1 |
| Level 2 |
| Level 3 |
| Total |
| ||||
|
|
|
|
|
|
|
|
|
| ||||
December 31, 2009 |
|
|
|
|
|
|
|
|
| ||||
|
|
|
|
|
|
|
|
|
| ||||
Mutual funds |
| $ | 17,132,355 |
| $ | |
| $ | |
| $ | 17,132,355 |
|
USANA Health Sciences, Inc. common stock |
| 2,210,424 |
| |
| |
| 2,210,424 |
| ||||
Participant loans |
| |
| |
| 794,563 |
| 794,563 |
| ||||
|
|
|
|
|
|
|
|
|
| ||||
|
| $ | 19,342,779 |
| $ | |
| $ | 794,563 |
| $ | 20,137,342 |
|
|
|
|
|
|
|
|
|
|
| ||||
December 31, 2008 |
|
|
|
|
|
|
|
|
| ||||
|
|
|
|
|
|
|
|
|
| ||||
Mutual funds |
| $ | 12,235,157 |
| $ | |
| $ | |
| $ | 12,235,157 |
|
USANA Health Sciences, Inc. common stock |
| 2,412,761 |
| |
| |
| 2,412,761 |
| ||||
Participant loans |
| |
| |
| 633,556 |
| 633,556 |
| ||||
|
|
|
|
|
|
|
|
|
| ||||
|
| $ | 14,647,918 |
| $ | |
| $ | 633,556 |
| $ | 15,281,474 |
|
The USANA Health Sciences, Inc. common stock unitized fund primarily includes Company common stock, the value of which is measured using the quoted market price. A small portion of this fund consists of cash held in a money market account. The money market portion of this fund provides liquidity, which enables Plan participants to transfer money daily among all investment choices. The fair value of this fund is based on Level 1 inputs as described above.
USANA Health Sciences 401(k) Plan
NOTES TO FINANCIAL STATEMENTS - CONTINUED
NOTE D FAIR VALUE MEASUREMENTS CONTINUED
The following table sets forth a summary of changes in the fair value of the Plans level 3 assets for the year ended December 31, 2009:
|
| Participant |
| |
Balance, beginning of year |
| $ | 633,556 |
|
Loans, net of repayments |
| 161,007 |
| |
|
|
|
| |
Balance, end of year |
| $ | 794,563 |
|
NOTE E RELATED-PARTY TRANSACTIONS
Plan assets include common stock of the Company totaling $2,210,424 as of December 31, 2009 ($2,412,761 as of December 31, 2008). The Company is the Plan Administrator as defined by the Plan and, therefore, transactions with respect to shares of the Companys common stock qualify as party-in-interest transactions. The Plan held 66,513 shares of common stock of the Company as of December 31, 2009 (68,196 shares as of December 31, 2008).
Loans to Plan participants, totaling $794,563 as of December 31, 2009 ($633,556 as of December 31, 2008), are also considered party-in-interest transactions. Interest income pertaining to participant loans totaled $42,861 for 2009.
NOTE F PLAN TERMINATION
Although it has not expressed any intent to do so, the Company has the right under the Plan to discontinue the Companys contributions at any time and to terminate the Plan subject to the provisions of ERISA. In the event of Plan termination, participants would become 100 percent vested in their accounts.
NOTE G TAX STATUS
The Plan has adopted a Non-Standardized Prototype Plan for which the Internal Revenue Service has issued a favorable opinion letter, dated March 31, 2008, covering the qualification of the Plan. The Plan Administrator and its qualified tax counsel do not anticipate that changes in the Plan after the date of the Internal Revenue Service opinion letter will affect the qualified and tax-exempt status of the Plan. Accordingly, the financial statements of the Plan do not include an income tax provision.
USANA Health Sciences 401(k) Plan
SUPPLEMENTAL INFORMATION
Employer Identification Number: 87-0500306
Plan Number: 001
SCHEDULE H, PART IV, line 4(i)
SCHEDULE OF ASSETS (HELD AT END OF YEAR)
As of December 31, 2009
( a ) |
| ( b ) |
| ( c) |
| SHARES, |
| ( e ) |
| |
|
|
|
|
|
|
|
|
|
| |
* |
| USANA Health Sciences, Inc. |
| Common Stock held in unitized fund ($112,027 cash) |
| 66,513 |
| $ | 2,210,424 |
|
|
|
|
|
|
|
|
|
|
| |
|
| The Growth Fund of America |
| Mutual Fund |
| 104,864 |
| 2,864,086 |
| |
|
| EuroPacific Growth Fund |
| Mutual Fund |
| 64,891 |
| 2,486,288 |
| |
|
| Washington Mutual Investors Fund |
| Mutual Fund |
| 88,629 |
| 2,182,328 |
| |
|
| SMALLCAP World Fund |
| Mutual Fund |
| 61,396 |
| 1,935,743 |
| |
|
| Fundamental Investors |
| Mutual Fund |
| 39,371 |
| 1,287,068 |
| |
|
| The Income Fund of America |
| Mutual Fund |
| 83,069 |
| 1,286,710 |
| |
|
| American Balanced Fund |
| Mutual Fund |
| 45,049 |
| 728,708 |
| |
|
| New World of America |
| Mutual Fund |
| 14,086 |
| 664,533 |
| |
|
| The Bond Fund of America |
| Mutual Fund |
| 45,564 |
| 537,330 |
| |
|
| American High-Income Trust |
| Mutual Fund |
| 40,223 |
| 426,743 |
| |
|
| U.S. Government Securities Fund |
| Mutual Fund |
| 28,418 |
| 397,044 |
| |
|
| American Funds 2040 Target Date |
| Mutual Fund |
| 21,035 |
| 179,215 |
| |
|
| American Funds 2045 Target Date |
| Mutual Fund |
| 17,153 |
| 146,826 |
| |
|
| American Funds 2050 Target Date |
| Mutual Fund |
| 16,020 |
| 135,045 |
| |
|
| American Funds 2030 Target Date |
| Mutual Fund |
| 13,845 |
| 117,543 |
| |
|
| American Funds 2025 Target Date |
| Mutual Fund |
| 13,428 |
| 112,530 |
| |
|
| American Funds 2015 Target Date |
| Mutual Fund |
| 10,578 |
| 91,088 |
| |
|
| American Funds 2035 Target Date |
| Mutual Fund |
| 8,563 |
| 72,612 |
| |
|
| American Funds 2020 Target Date |
| Mutual Fund |
| 2,991 |
| 25,306 |
| |
|
| American Funds 2010 Target Date |
| Mutual Fund |
| 2,383 |
| 20,562 |
| |
|
|
|
|
|
|
|
|
|
| |
|
| Money Market Fund |
| Money Market Fund |
|
|
| 1,435,047 |
| |
|
|
|
|
|
|
|
|
|
| |
* |
| Loans to participants |
| Loans with |
| 199 |
| 794,563 |
| |
|
|
|
|
|
|
|
|
|
| |
|
|
|
|
|
|
|
| $ | 20,137,342 |
|
* Party-in-interest
Note - Column ( d ), cost, is not required because all investments are participant directed.
Exhibit |
|
|
Number |
| Description |
|
|
|
23.1 |
| Consent of Independent Registered Public Accounting Firm (filed herewith) |
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this annual report to be signed on its behalf by the undersigned thereunto duly authorized.
|
|
| USANA Health Sciences 401 (k) Plan |
|
|
|
|
|
|
|
|
Date: | June 17, 2010 |
| /s/ Jeffrey A. Yates |
|
|
| Jeffrey A. Yates |
|
|
| Chief Financial Officer |